KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATLeasesLoans and Notes ReceivablesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherReceivables Refunds
Ratios

Astrana Health (ASTH) Loans and Notes Receivables (2019 - 2025)

Astrana Health's Loans and Notes Receivables history spans 5 years, with the latest figure at $973000.0 for Q1 2023.

  • For Q1 2023, Loans and Notes Receivables fell 75.68% year-over-year to $973000.0; the TTM value through Mar 2023 reached $973000.0, down 75.68%, while the annual FY2022 figure was $996000.0, 75.1% down from the prior year.
  • Loans and Notes Receivables for Q1 2023 was $973000.0 at Astrana Health, down from $996000.0 in the prior quarter.
  • Across five years, Loans and Notes Receivables topped out at $22.9 million in Q4 2019 and bottomed at $973000.0 in Q1 2023.
  • The 5-year median for Loans and Notes Receivables is $4.0 million (2021), against an average of $6.2 million.
  • The largest annual shift saw Loans and Notes Receivables tumbled 75.1% in 2022 before it plummeted 75.68% in 2023.
  • A 5-year view of Loans and Notes Receivables shows it stood at $22.9 million in 2019, then tumbled by 71.97% to $6.4 million in 2020, then tumbled by 37.74% to $4.0 million in 2021, then crashed by 75.1% to $996000.0 in 2022, then dropped by 2.31% to $973000.0 in 2023.
  • Per Business Quant, the three most recent readings for ASTH's Loans and Notes Receivables are $973000.0 (Q1 2023), $996000.0 (Q4 2022), and $4.0 million (Q1 2022).